Cathepsin S (CTSS or EC 3.4.22.27) Pipeline Report: Guide Features Descriptive Drug Profiles & Other Developmental Activities

Cathepsin S (CTSS or EC 3.4.22.27) – Pipeline Review, H1 2018, outlays comprehensive information on the Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Pune, India – March 29, 2018 /MarketersMedia/ —

Cathepsin S (CTSS or EC 3.4.22.27) – Cathepsin S is a lysosomal enzyme that belongs to the papain family of cysteine proteases. Cathepsin S has a role in itch and pain, or nociception. The nociceptive activity results from cathepsin S functioning as a signaling molecule via activation of protease-activated receptors 2 and 4 members of the G-protein coupled receptor family. Cathepsin S has a physiological role outside the lysosome.
Report Source: https://www.themarketreports.com/report/cathepsin-s-ctss-or-ec-342227-pipeline-review-h1-2018
Scope
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics and enlists all their major and minor projects
• The report assesses Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news and deals related to Cathepsin S (CTSS or EC 3.4.22.27) targeted therapeutics
Purchase this report at: https://www.themarketreports.com/report/buy-now/1036790
Reasons To Buy
• Identify the use of drugs for target identification and drug repurposing
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding Cathepsin S (CTSS or EC 3.4.22.27) development landscape
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1036790

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/cathepsin-s-ctss-or-ec-3-4-22-27-pipeline-report-guide-features-descriptive-drug-profiles-other-developmental-activities/322620

For more information, please visit https://www.themarketreports.com/report/cathepsin-s-ctss-or-ec-342227-pipeline-review-h1-2018%20%20

Source: MarketersMedia

Release ID: 322620